14-day Premium Trial Subscription Try For FreeTry Free
First quarter revenue growth driven by continued strong uptake of the CGuard™ Embolic Prevention System (EPS) in the company’s major markets Management to host investor.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) Acceleron Pharma Inc (NASDAQ...
Bad (economic) news is good news. Commodities are a bellwether. Q1 earnings beating expectations. Fiscal stimulus affecting money supply. Business conditions su
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Pandemic risks exacerbating economic and social divisions between countries
TEL AVIV, Israel, May 05, 2020 -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid.

Equinix: In A Single Metric

09:05pm, Friday, 01'st May 2020
Equinix shares have recently reached their 52wk high, in spite of market turbulence. We believe EQIX is benefiting from secular trends, but also unique among da
Kraft Heinz delivered better-than-expected results for the first quarter. The company benefited from pantry loading amid the COVID-19 pandemic.
Q4 2019 InspireMD Inc Earnings Call
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InspireMD (NSPR), IDEAYA Biosciences (IDYA) and Capricor
Shareholders in InspireMD, Inc. (NYSEMKT:NSPR) had a terrible week, as shares crashed 33% to US$0.64 in the week since...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InspireMD (NSPR) and Paratek Pharmaceuticals (PRTK) with
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE